Analysts at Barclays downgraded Valeant Pharmaceuticals International, Inc. (VRX) from ‘Overweight’ to ‘Equal Weight’ in a research report issued to clients on Monday.
The target price for VRX is lowered from $135 to $34.
Shares of the $10.04 billion market cap company are down 86.65% year-over-year and 73.46% year-to-date.
VRX rose $2.46 to $29.44 in recent trading.
Juniper Networks, Inc. (JNPR) was downgraded from ‘Neutral’ to ‘Reduce’ at Sun Trust Rbsn Humphrey.
Shares have traded today between $25.77 and $26.27 with the price of the stock fluctuating between $21.49 to $32.39 over the last 52 weeks.
On valuation metrics, Juniper Networks Inc. shares are currently changing hands at 16.25x this year’s forecasted earnings, compared to the industry’s 20.28x earnings multiple. Ticker has a t-12 price/sales ratio of 2.08. EPS for the same period registers at $1.59.
Shares of Juniper have lost $0.56 to $25.83 in midday trading on Monday, giving it a market cap of roughly $9.9 billion. The stock traded as high as $32.39 on Nov. 4, 2015.
Bernstein reported on Monday that they have lowered their rating for Intel Corporation (INTC). The firm has downgraded INTC from ‘Market Perform’ to ‘Underperform’ noting a weak 1Q still exists. Firm sets its INTC price target at $26.
Intel Corp. recently traded at $32.26, a loss of $0.42 over Friday’s closing price. The name has a current market capitalization of $152.40 billion.
As for passive income investors, the chipmaker pays shareholders $1.04 per share annually in dividends, yielding 3.25%. Five year average dividend yield currently stands at 3.27%.
NetApp, Inc. (NTAP) had its rating lowered from ‘Neutral’ to ‘Underperform’ by analysts at Macquarie on Monday.
Currently there are 2 analysts that rate NTAP a ‘Buy’, 8 analysts rate it a ‘Sell’, and 26 rate it a ‘Hold’.
NTAP was down $0.54 at $26.70 in midday trade, moving within a 52-week range of $20.66 to $37.07. The name, valued at $7.81 billion, opened at $26.58.
As for passive income investors, the firm pays stockholders $0.72 per share annually in dividends, yielding 2.64%.